Vitrolife agreed to collaborate with Cellartis regarding the development of new products for cultivation, handling, and differentiation of stem cells. The two-year deal extends the present collaboration between the companies.
Cellartis focuses on research, development, and production of human embryonic stem cells and differential cells derived for stem cells. Vitrolife is a global biotechnology/medical device group that works with developing, manufacturing, and selling advanced products and systems for the preparation, cultivation and storage of human cells, tissue, and organs.